Eris Lifesciences Ltd Q2 FY26 Results:-

ERIS

Net Profit: ₹134.1 Cr (↑3.6% YoY | ↑6.9% QoQ) Revenue: ₹792.4 Cr (↑6.9% YoY | ↑2.5% QoQ) EBITDA: ₹214.0 Cr (↑9.3% YoY | ↑3.2% QoQ) EBITDA Margin: 27.0% ↑ vs 26.3% (YoY) | ↑ vs 26.5% (QoQ)